CDT Equity (CDT) Net Income (2022 - 2026)
CDT Equity's (CDT) quarterly Net Income came in at -$4.6 million in Q2 2026, up 24.49% on a YoY basis from -$3.7 million in Q2 2025, and down 12.78% quarter-over-quarter from -$4.0 million in Q1 2026.
Analysis
CDT Equity (CDT) Net Income (2022 - 2026) Analysis & Trends
CDT Equity (CDT) has reported Net Income for 5 consecutive years, with -$4.6 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Net Income rose 24.49% year-over-year to -$4.6 million; the trailing twelve-month figure through Jun 2026 stood at -$36.9 million (down 51.68% YoY), and the FY2025 full-year result was -$40.3 million, down 76.21% from the prior year.
- Net Income eased to -$4.6 million in Q2 2026 per CDT's latest filing, from -$4.0 million in the prior quarter.
- Across five years, Net Income topped out at $562808.0 in Q4 2022 and bottomed at -$21.1 million in Q4 2025.
- Historically, Net Income has averaged -$4.1 million across 5 years, with a median of -$3.9 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Net Income jumped 147.44% in 2023, then slumped 3175.61% in 2024.
- Over 5 years, Net Income stood at $562808.0 in 2022, then tumbled by 632.86% to -$3.0 million in 2023, then sank by 124.74% to -$6.7 million in 2024, then tumbled by 212.85% to -$21.1 million in 2025, then jumped by 78.4% to -$4.6 million in 2026.
- According to Business Quant data, Net Income over the past three periods registered -$4.6 million, -$4.0 million, and -$21.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | 5.28 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | -238.00 Mn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | 2.16 Bn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | -644.37 Mn |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | 585.61 Mn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | 333.00 Mn |
| 10 | CDT Equity | 187,135.95 | 187,135.95 | - | -4.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4.56 Mn |
| Mar 31, 2026 | -4.04 Mn |
| Dec 31, 2025 | -21.09 Mn |
| Sep 30, 2025 | -7.27 Mn |
| Jun 30, 2025 | -6.03 Mn |
| Mar 31, 2025 | -4.76 Mn |
| Dec 31, 2024 | -6.74 Mn |
| Sep 30, 2024 | -6.83 Mn |
| Jun 30, 2024 | -5.60 Mn |
| Mar 31, 2024 | -3.70 Mn |
| Dec 31, 2023 | -3.00 Mn |
| Sep 30, 2023 | -726,000.00 |
| Jun 30, 2023 | -343,711.00 |
| Mar 31, 2023 | 120,269.00 |
| Dec 31, 2022 | 562,808.00 |
| Sep 30, 2022 | 206,906.00 |
| Jun 30, 2022 | -117,539.00 |
| Mar 31, 2022 | -253,536.00 |